Apple’s Steve Jobs is Considering Liver Transplant

16 Jan

Steve Jobs, CEO of Apple Inc. is considering a liver transplant as a result of complications after treatment for pancreatic cancer in 2004, according to Bloomberg.

In a statement released Jan. 5, Jobs said he was suffering from a “hormone imbalance” and that the remedy for his weight loss was “relatively simple.” On Jan. 14, he announced that he was taking a five-month medical leave because his health issues were “more complex” than he originally thought.

In a telephone interview today, Jobs told Bloomberg he wouldn’t comment further on his health.

Jobs said in 2004 that he underwent surgery to remove a neuroendocrine islet cell tumor, a rare, slow-growing type of cancer that affects as many as 3,000 people in the U.S. annually. These tumors are distinguished by their tendency to overproduce hormones such as insulin. Excess hormones can lead to low blood sugar, low blood pressure or other symptoms.Neuroendocrine tumors that originate in the pancreas, as Jobs’s did, often spread to the liver. One option doctors have in these cases is to perform a liver transplant.

Apple, based in Cupertino, California, fell $1.05 to $82.33 at 4 p.m. New York time today in Nasdaq Stock Market trading. The shares lost 57 percent last year.

Here’s the full Bloomberg wire story.

One Response to “Apple’s Steve Jobs is Considering Liver Transplant”

  1. coffee January 19, 2009 at 5:33 pm #

    crazy that Steve Jobs had to leave for a while, hopefully there’s somebody to hold up the fort while he’s gone

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: